Biocon Biologics to reduce the cost of human insulin and cancer drugs

The Biocon subsidiary will chart a path that ensures high volumes and lowcosts, unlike competitors, Christiane Hamacher, chief executive of Biocon Biologics told ET.

from technology - Technology News | Latest Technology & Startups Industry Information and Updates: ET Tech : ETtech.com https://ift.tt/2RcdZVI

Post a Comment

0 Comments